First Time Loading...

Qualigen Therapeutics Inc
NASDAQ:QLGN

Watchlist Manager
Qualigen Therapeutics Inc Logo
Qualigen Therapeutics Inc
NASDAQ:QLGN
Watchlist
Price: 0.282 USD -7.54% Market Closed
Updated: May 29, 2024

Qualigen Therapeutics Inc
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Qualigen Therapeutics Inc
Total Equity Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
Qualigen Therapeutics Inc
NASDAQ:QLGN
Total Equity
-$2.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Total Equity
$8B
CAGR 3-Years
-16%
CAGR 5-Years
N/A
CAGR 10-Years
5%
Gilead Sciences Inc
NASDAQ:GILD
Total Equity
$17.5B
CAGR 3-Years
-3%
CAGR 5-Years
-4%
CAGR 10-Years
3%
Amgen Inc
NASDAQ:AMGN
Total Equity
$5B
CAGR 3-Years
-19%
CAGR 5-Years
-14%
CAGR 10-Years
-14%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Total Equity
$18.5B
CAGR 3-Years
27%
CAGR 5-Years
31%
CAGR 10-Years
31%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Total Equity
$27B
CAGR 3-Years
31%
CAGR 5-Years
23%
CAGR 10-Years
28%

See Also

What is Qualigen Therapeutics Inc's Total Equity?
Total Equity
-2.1m USD

Based on the financial report for Dec 31, 2023, Qualigen Therapeutics Inc's Total Equity amounts to -2.1m USD.